| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Operating Officer
1 company
Mark Oldakowski is Chief Operating Officer at BNGO. Mark Oldakowski's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1K at current prices.
Net of sales, the BNGO filings show accumulation of 815 shares.
Mark Oldakowski has 23 Form 4 filings on record from August 2018 to August 2026, all as Chief Operating Officer at Bionano Genomics (BNGO), 2018–2026.
The 27 reported transactions were 11 option or other derivative awards, 9 tax withholdings, 4 stock awards and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $5K and no sales.
The only open-market purchase was 815 shares of BNGO at an average $6.13 on August 23, 2018, about $5K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2018 | BNGO Bionano Genomics, Inc. | Chief Operating Officer | Buy | 815 | $6.13 | $4,991.88 | New |